Letter by Wells and Eisenberg regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials". uri icon

Overview

publication date

  • December 7, 2010

Research

keywords

  • C-Reactive Protein
  • Cardiovascular Diseases
  • Clinical Trials as Topic
  • Dyslipidemias
  • Fluorobenzenes
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrimidines
  • Sulfonamides

Identity

Scopus Document Identifier

  • 78650710489

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.110.953216

PubMed ID

  • 21135368

Additional Document Info

volume

  • 122

issue

  • 23